Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
about
Novel therapeutic targets in Helicobacter pylori.Cholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccineHelicobacter pylori- inflammation, immunity and vaccines.Effect of Different Adjuvants on Protection and Side-Effects Induced by Helicobacter suis Whole-Cell Lysate Vaccination.The current status of Helicobacter pylori vaccines: a review.Improving vaccines by incorporating immunological coadjuvants.Vaccinating against Helicobacter pylori in the developing world.Combination adjuvants: the next generation of adjuvants?Recent progress concerning CpG DNA and its use as a vaccine adjuvant.Role of Toll-like receptors in Helicobacter pylori infection and immunity.The study of H. pylori putative candidate factors for single- and multi-component vaccine development.Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.Sublingual vaccination with sonicated Salmonella proteins and mucosal adjuvant induces mucosal and systemic immunity and protects mice from lethal enteritis.Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
P2860
Q33195402-C613A31A-01E8-44F7-91AD-E60B458C0EB3Q35520692-0A554E1E-6911-4E9A-BBBA-4082786094D4Q35583570-143DE1C9-5EDE-456E-A139-9D9B1E02DBBBQ35675819-3D0D11CF-6E31-49EB-88D6-5570B6D5EACAQ36740010-FB564BDB-EB0C-482A-B054-B547740DE454Q36899084-20AF97C5-D9A4-4A94-A46D-70057B4E13BFQ37591512-E7687DC9-3B62-44F4-9D02-AA881FA872AFQ37821483-4FC0F828-9347-400B-B833-A5BFADA42456Q38168903-E07F3FB5-6C83-4605-9897-667628D5E281Q38240875-1DC770CD-88BC-45A1-AA4C-7DE12F99F72AQ39350897-EBE34C40-4164-42C9-8465-84E806CFF140Q41184340-B4442C64-04CC-49F9-B7A0-0660FAD16F5BQ46734851-5CE7A536-16C9-4284-9C45-19777E622796Q50041664-26505F13-E4FE-43CF-B996-5E4AD9CA5EDEQ54452577-1EA6D835-425D-43E6-85E8-F69A7F280012
P2860
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@ast
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@en
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@nl
type
label
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@ast
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@en
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@nl
prefLabel
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@ast
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@en
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@nl
P2093
P2860
P1476
Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
@en
P2093
Bruce F Smith
Henry J Baker
Weiwen Jiang
P2860
P356
10.1128/IAI.71.1.40-46.2003
P407
P577
2003-01-01T00:00:00Z